Evaluation of the efficacy of atorvastatin in patients with CKD
- Conditions
- CKD patients
- Registration Number
- JPRN-UMIN000009393
- Lead Sponsor
- Division of Nephrology, Juntendo University Faculty of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 50
Not provided
Patients are excluded if they are compatible with any one of the following criteria. 1. Patients with a history of hypersensitivity for an ingredient of atorvastatin. 2. Patients whose liver function is thought to decrease; acute hepatitis, acute aggravation of the chronic hepatitis, cirrhosis, liver cancer, jaundice 3. A pregnant woman or the woman who may be pregnant and nursing mother. 4. Patients receiving telaprevir. 5. Patients with significant psychic disturbance or drug dependence disease or alcoholism. 6. Patients that going to hospital of all follow-up seems to be impossible. 7. Patients who are not able to understand a test instruction from medical experts of the client side or the doctors involved in the study. 8. Patients who judged as inadequate by the doctors involved in the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Amount of urinary albumin
- Secondary Outcome Measures
Name Time Method 1.Lipid metabolism: LDL, HDL, TG, Apolipoprotein fractionation, MDA-LDL 2.High sensitive CRP 3.ADMA 4.Urinary L-FABP 5.Urinary 8-OHdG 6.ABI and CAVI 7.Carotid ultrasonography 8.Examination of the fundus